Biora Therapeutics Analyst Ratings
Biora Therapeutics Analyst Ratings
While ratings are subjective and will change, the latest Biora Therapeutics (BIOR) rating was a maintained with a price target of $65.00 to $50.00. The current price Biora Therapeutics (BIOR) is trading at is $2.17, which is out of the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/02/2023 | 2204.15% | HC Wainwright & Co. | $65 → $50 | Maintains | Buy |
| 08/15/2023 | 2895.39% | HC Wainwright & Co. | → $65 | Reiterates | Buy → Buy |
| 07/27/2023 | 2895.39% | HC Wainwright & Co. | → $65 | Reiterates | Buy → Buy |
| 05/16/2023 | 2895.39% | HC Wainwright & Co. | → $65 | Reiterates | Buy → Buy |
| 01/10/2023 | 2895.39% | HC Wainwright & Co. | $6 → $65 | Maintains | Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 2023 年 2 月 10 日 | 2204.15% | HC Wainwright & Co. | 65 美元 → 50 美元 | 維護 | 購買 |
| 08/15/2023 | 2895.39% | HC Wainwright & Co. | → 65 美元 | 重申 | 購買 → 購買 |
| 07/27/2023 | 2895.39% | HC Wainwright & Co. | → 65 美元 | 重申 | 購買 → 購買 |
| 05/16/2023 | 2895.39% | HC Wainwright & Co. | → 65 美元 | 重申 | 購買 → 購買 |
| 01/10/2023 | 2895.39% | HC Wainwright & Co. | 6 美元 → 65 美元 | 維護 | 購買 |
What is the target price for Biora Therapeutics (BIOR)?
Biora Therapeutics（BIOR）的目標價格是多少？
The latest price target for Biora Therapeutics (NASDAQ: BIOR) was reported by HC Wainwright & Co. on October 2, 2023. The analyst firm set a price target for $50.00 expecting BIOR to rise to within 12 months (a possible 2204.15% upside). 5 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 於2023年10月2日公佈了Biora Therapeutics（納斯達克股票代碼：BIOR）的最新目標股價。該分析公司將目標股價定爲50.00美元，預計BIOR將在12個月內升至2204.15％（可能上漲2204.15％）。去年有5家分析公司公佈了評級。
What is the most recent analyst rating for Biora Therapeutics (BIOR)?
分析師對Biora Therapeutics（BIOR）的最新評級是多少？
The latest analyst rating for Biora Therapeutics (NASDAQ: BIOR) was provided by HC Wainwright & Co., and Biora Therapeutics maintained their buy rating.
Biora Therapeutics（納斯達克股票代碼：BIOR）的最新分析師評級由HC Wainwright & Co. 提供，Biora Therapeutics維持買入評級。
When is the next analyst rating going to be posted or updated for Biora Therapeutics (BIOR)?
Biora Therapeutics（BIOR）的下一個分析師評級何時公佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Biora Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Biora Therapeutics was filed on October 2, 2023 so you should expect the next rating to be made available sometime around October 2, 2024.
分析師在進行了廣泛的研究後得出了股票評級，包括閱讀公開財務報表、與Biora Therapeutics的高管和客戶交談以及聽取業績電話會議。大多數分析師每三個月進行一次評級，因此每家公司每年應獲得4個評級。Biora Therapeutics的最後一次評級是在2023年10月2日提交的，因此你應該預計下一個評級將在2024年10月2日左右公佈。
Is the Analyst Rating Biora Therapeutics (BIOR) correct?
分析師對 Biora Therapeutics (BIOR) 的評級正確嗎？
While ratings are subjective and will change, the latest Biora Therapeutics (BIOR) rating was a maintained with a price target of $65.00 to $50.00. The current price Biora Therapeutics (BIOR) is trading at is $2.17, which is out of the analyst's predicted range.
儘管評級是主觀的，並且會發生變化，但最新的Biora Therapeutics（BIOR）評級保持不變，目標股價爲65.00美元至50.00美元。Biora Therapeutics（BIOR）目前的交易價格爲2.17美元，超出了分析師的預期區間。
譯文內容由第三人軟體翻譯。
